Skip to main content
. 2020 Jan 6;20:12. doi: 10.1186/s12885-019-6425-3

Table 2.

Correlation of ARID1a, BRG1 and BRM expression for the test corhort

ARID1a expression BRG1 expression BRM expression
Negative Positive p-value Negative Positive p-value Negative Positive p-value
Total 147* 14 9.5% 133 90.5% 149* 7 4.7% 142 95.3% 148* 17 11.5% 131 88.5%
Sex
 Female 13 8.8% 1 7.7% 12 92.3% 1.000 14 9.4% 0 0.0% 14 100.0% 1.000 14 9.5% 2 14.3% 12 85.7% 0.664
 Male 134 13.2% 13 9.7% 121 90.3% 135 90.6% 7 5.2% 128 94.8% 134 90.5% 15 11.2% 119 88.8%
Age group
 <65 63 46.3% 5 7.9% 58 92.1% 0.771 65 47.1% 2 3.1% 63 96.9% 0.447 65 47.4% 7 10.8% 58 89.2% 0.796
 >65 73 53.7% 8 11.0% 65 89.0% 73 52.9% 5 6.8% 68 93.2% 72 52.6% 9 12.5% 63 87.5%
pT stage
 1 21 14.4% 2 9.5% 19 90.5% 0.583 21 14.2% 1 4.8% 20 95.2% 0.107 21 14.3% 3 14.3% 18 85.7% 0.496
 2 13 8.9% 0 0.0% 13 100.0% 13 8.8% 0 0.0% 13 100.0% 13 8.8% 0 0.0% 13 100.0%
 3 109 74.7% 12 11.0% 97 89.0% 111 75.0% 5 4.5% 106 95.5% 110 74.8% 14 12.7% 96 87.3%
 4 3 2.1% 0 0.0% 3 100% 3 2.0% 1 0.0% 2 100% 3 2.0% 0 0.0% 3 100.0%
Lymph node metastasis
 pN0 54 37.0% 6 11.1% 48 88.9% 0.656 54 36.5% 3 5.6% 51 94.4% 0.832 54 36.7% 5 9.3% 49 90.7% 0.574
 pN 1 71 48.6% 5 7.0% 66 93.0% 71 48.0% 3 4.2% 68 95.8% 70 47.6% 8 11.4% 62 88.6%
 pN 2 10 6.8% 1 10.0% 9 90.0% 10 6.8% 0 0.0% 10 100.0% 10 6.8% 1 10.0% 9 90.0%
 pN 3 11 7.5% 2 18.2% 9 81.8% 13 8.8% 1 7.7% 12 92.3% 13 8.8% 3 23.1% 10 76.9%
Grading
 G1 0 0.0% 0 0.0% 0 0.0% 0.095 1 0.8% 0 0.0% 1 100.0% 0.901 1 0.8% 0 0.0% 1 100.0% 0.123
 G2 84 68.9% 5 6.0% 79 94.0% 84 67.7% 3 3.6% 81 96.4% 83 67.5% 8 9.6% 75 90.4%
 G3 38 31.1% 6 15.8% 32 84.2% 39 31.5% 2 5.1% 37 94.4% 39 31.7% 9 23.1% 30 76.9%

*Total numbers of patients do not add due to missing clinical data in some cases